Human papillomavirus (HPV) vaccines administered in 3 doses over a period of 6 months can help prevent cervical cancer but cost (almost $400 for the 3-dose regimen in the United States) may limit its use in countries with fewer resources…. Read More ›
Despite conflicting guidelines for cervical cancer screening during the past several years, fewer women received unnecessary Pap tests in 2010 than in 2000, according to a pair of analyses published in the Morbidity and Mortality Weekly Report by scientists from… Read More ›
Cancer rates worldwide are expected to increase by 75% by 2030, according to the first analysis to examine global cancer patterns according to individual countries’ development levels. In some of the world’s poorest countries, the analysis indicates that cancer rates… Read More ›
Boys aged 11 and 12 years should be routinely vaccinated against the human papillomavirus (HPV) to protect them against anal cancer and cancers of the mouth and throat that are associated with sexually transmitted HPV infection, an advisory panel to… Read More ›
Programs to vaccinate girls against human papillomavirus (HPV), which is responsible for 70% of cervical cancers, have produced higher vaccination rates in Canada, Panama, and Mexico than in the United States. The Centers for Disease Control and Prevention reported the… Read More ›
A vaccine against certain strains of the human papillomavirus (HPV), now routinely given to girls to help prevent cervical cancer, reduces the risk of anal infection by the same HPV strains, which are also associated with the development of anal… Read More ›
